Representing

E - bonitete

Billev Pharma East

Company: Billev Pharma East
Address: Tržaška cesta 202, 1000 LJUBLJANA

Google maps
Municipality: Ljubljana
Region: Central Slovenia (Osrednjeslovenska)
Contacts: 00386 12322095

http://www.billeveast.com
Company management: Director: Vito Strasberger
Extract of management responsible for a company's business operations abroad: Katja Pečjak,
Sebastjan Reven,
Registration number: 2289423
Tax number: 11022485
Organisational form: Limited Liability Company
Source of capital: Foreign
Size of company: Small
Exports share in income: 47,00 %
Tradition since: 2007
Extract of target regions and countries where a company exports: France
Germany
Hungary
United Kingdom
United States
Description of company: Billev Pharma East was established in Ljubljana 2007. The company was at that time a sister company to Billev Pharma ApS, Denmark with the same owner. The owner Peter de Mayo Billev established Billev Pharma as one of the first regulatory affairs consultancy companies in Europe in 1978. Since the very beginning, it has been our vision to be early to provide assistance with the growing amount of new legislation through active participation in the preparatory work for rules and regulations through international organisations.
Description of products and services:
Expert services in the field of regulatory, medical and pharmacovigilance for:
- Human medicinal products,
- Veterinary medicinal products,
- Herbal medicinal products,
- Medical devices,
- Radiopharmaceuticals,
- Vaccines,
- Food supplements
- Biocides.
Classification of company:
Main activity in accordance with the NACE classification
69.103 Other legal activities
Activities in accordance with the CPA classification
69.10.19 Other legal services
Field of activity: Services
Healthcare and Medical Industry
Credit rating information:
10/10
EXCELLENT credit ratingOrder credit report
Credit rating information provided by EBONITETE.SI
Information on the presentation card companies are obtained from surveys. Financial data are for the financial year 2022, last update 30.06.2023.
Last data update 22.04.2024.